Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer by Sarah Derks, Hanneke W. M. van Laarhoven

Get full text

Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity by Tom van den Bosch, Sarah Derks, Daniël M. Miedema

Get full text

Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives by Tesfay M. Godefa, Sarah Derks, Victor L. J. L. Thijssen

Get full text

Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy... by Maurice vanDuijvenvoorde, Sarah Derks, Idris Bahce, C René Leemans, Rieneke van deVen, Marieke F Fransen

Get full text

Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer? by Ruben S. A. Goedegebuure, Leonie K. de Klerk, Leonie K. de Klerk, Adam J. Bass, Adam J. Bass, Sarah Derks, Victor L. J. L. Thijssen, Victor L. J. L. Thijssen

Get full text

Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study by Marieke Pape, Pauline A. J. Vissers, Willemieke P. M. Dijksterhuis, David Bertwistle, Laura McDonald, Bianca Mostert, Sarah Derks, Irma M. Oving, Rob H. A. Verhoeven, Hanneke W. M. van Laarhoven

Get full text

Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations by Tessa S. Groen-van Schooten, Tessa S. Groen-van Schooten, Tessa S. Groen-van Schooten, Micaela Harrasser, Micaela Harrasser, Micaela Harrasser, Jens Seidel, Jens Seidel, Jens Seidel, Emma N. Bos, Emma N. Bos, Emma N. Bos, Tania Fleitas, Monique van Mourik, Monique van Mourik, Roos E. Pouw, Ruben S. A. Goedegebuure, Ruben S. A. Goedegebuure, Benthe H. Doeve, Benthe H. Doeve, Jasper Sanders, Jasper Sanders, Jasper Sanders, Joris Bos, Joris Bos, Joris Bos, Mark I. van Berge Henegouwen, Mark I. van Berge Henegouwen, Victor L. J. L. Thijssen, Victor L. J. L. Thijssen, Victor L. J. L. Thijssen, Nicole C. T. van Grieken, Nicole C. T. van Grieken, Hanneke W. M. van Laarhoven, Hanneke W. M. van Laarhoven, Tanja D. de Gruijl, Tanja D. de Gruijl, Sarah Derks, Sarah Derks, Sarah Derks

Get full text

The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized cli... by Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, Fatima Carneiro, Ceu Figueiredo, Erika Ruiz, Maria Alsina, Cristina Molero, Marcelo Garrido, Arnoldo Riquelme, Carmelo Caballero, Eva Lezcano, Juan Manuel O’Connor, Federico Esteso, Judith Farrés, José Manuel Mas, Florian Lordick, Jeannette Vogt, Antonella Cardone, Charis Girvalaki, Andrés Cervantes, Tania Fleitas, on behalf of the members of LEGACy consortium

Get full text

Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition by Tom van den Ende, Aiarpi Ezdoglian, Lisanne M. Baas, Joyce Bakker, Sinéad M. Lougheed, Micaela Harrasser, Cynthia Waasdorp, Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof, Nadia Haj Mohammad, Richard van Hillegersberg, Stella Mook, Conny J. van der Laken, Nicole C.T. van Grieken, Sarah Derks, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven, Tanja D. de Gruijl

Get full text

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT) by Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, Stephanie O van der Woude, Ron AA Mathôt, Marije Slingerland, Judith de Vos-Geelen, Massimo Zucchetti, Cristina Matteo, Erik van Dijk, Bauke Ylstra, Victor Thijssen, Sarah Derks, Tesfay Godefa, Willemieke Dijksterhuis, Gerben E Breimer, Otto M van Delden, Rob HA Verhoeven, Sybren L Meijer, Maarten F Bijlsma, Hanneke WM van Laarhoven

Get full text

Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival by Hui Zheng, Eirini Pectasides, Mohamed Uduman, Charles S Fuchs, James M Cleary, Adam J Bass, Jérémy Augustin, Leonie K de Klerk, Anuj K Patel, Sarah Derks, Nihal Raman, Fahire G Akarca, Nadine J McCleary, Douglas A Rubinson, Jeffrey W Clark, Bridget Fitzpatrick, Lauren K Brais, Megan E Cavanaugh, Amanda J Rode, Melissa G Jean, Patrick H Lizotte, Matthew J Nazzaro, Peter C Enzinger

Get full text

Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group by Sanne Nieuwenhuizen, Robbert S. Puijk, Bente van den Bemd, Luca Aldrighetti, Mark Arntz, Peter B. van den Boezem, Anna M. E. Bruynzeel, Mark C. Burgmans, Francesco de Cobelli, Marielle M. E. Coolsen, Cornelis H. C. Dejong, Sarah Derks, Arjen Diederik, Peter van Duijvendijk, Hasan H. Eker, Anton F. Engelsman, Joris I. Erdmann, Jurgen J. Fütterer, Bart Geboers, Gerie Groot, Cornelis J. A. Haasbeek, Jan-Jaap Janssen, Koert P. de Jong, G. Matthijs Kater, Geert Kazemier, Johan W. H. Kruimer, Wouter K. G. Leclercq, Christiaan van der Leij, Eric R. Manusama, Mark A. J. Meier, Bram B. van der Meijs, Marleen C. A. M. Melenhorst, Karin Nielsen, Maarten W. Nijkamp, Fons H. Potters, Warner Prevoo, Floris J. Rietema, Alette H. Ruarus, Simeon J. S. Ruiter, Evelien A. C. Schouten, Gian Piero Serafino, Colin Sietses, Rutger-Jan Swijnenburg, Florentine E. F. Timmer, Kathelijn S. Versteeg, Ted Vink, Jan J. J. de Vries, Johannes H. W. de Wilt, Barbara M. Zonderhuis, Hester J. Scheffer, Petrousjka M. P. van den Tol, Martijn R. Meijerink

Get full text